The Uncorrected Proofs


After the authors have received the letter of acceptance and have paid the publication fee, the uncorrected version of their article appears instantly on our web site. It provides DOI and dates of acceptance and online posting.

This „early bird“ version of the article has been made available at this early stage in order to  provide the fastest access to the article and is not intended to be the final version. The manuscript will undergo copyediting, typesetting and review of the resulting proof before it is published in its final form. To be noted that changes to the article should not be requested at this stage; for the proofreading the authors will be contacted by the Editor. This first version of the article will be replaced by the final version as soon as the latter becomes available and moved from „Uncorrected proofs“ to the „Papers in press“.



Full paper in pdf

N. Kumar Jain, M. Tailang, N. Thangavel, H. A. Makeen, M. Albratty, A. Najmi, H. A. Alhazmi, K. Zoghebi, M. Alagusundaram, H. Kumar Jain and B. Chandrasekaran

A comprehensive overview of selective and novel fibroblast growth factor receptor

inhibitors as a potential anticancer modality


Full paper in pdf

M. Baković, M. Bago, L. Benić, M. Krajinović, T. Silovski, N. Dedić Plavetić, L. Turković, M. Sertić and M. Ortner Hadžiabdić

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors


Full paper in pdf

A. Dugonjić Okroša, T. Silovski, N. Dedić Plavetić, H. Silovski, A. Kovačić and I. Mucalo

Beliefs about medicines’ association with endocrine therapy adherence in early breast cancer survivors in Croatia


Full paper in pdf

J. Kovačić, D. Amidžić Klarić, N. Turk and A. Mornar

Size exclusion chromatography as green support for forced degradation study of adalimumab